Vanguard Global Advisers’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$159K Buy
28,930
+349
+1% +$1.82K ﹤0.01% 2573
2026
Q2
$181K Hold
28,581
– – ﹤0.01% 2537
2026
Q1
$97.7K Buy
+28,581
New +$96.3K ﹤0.01% 2740

Other funds holding ASPN

Vanguard Global Advisers's ASPN Position: Q3 2026 in Review

Vanguard Global Advisers increased its Aspen Aerogels (ASPN) stake by 1.2% in Q3 2026, buying an estimated $1.82K and bringing the position to 28,930 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

Vanguard Global Advisers first reported a position in ASPN in Q1 2026 and has held it in 3 quarters since. The position peaked at $181K in Q2 2026. 187 funds tracked by Wall St. Rank hold ASPN as of Q3 2026.

  • Vanguard Global Advisers held 28,930 shares of Aspen Aerogels worth $159K as of Q3 2026.
  • Vanguard Global Advisers bought 349 Aspen Aerogels shares in Q3 2026, an estimated $1.82K.
  • Aspen Aerogels made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2573 holding.
  • Vanguard Global Advisers first reported a position in Aspen Aerogels in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Aspen Aerogels position peaked at $181K in Q2 2026.
  • 187 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.